Hypercholesterolemia: Clinical Trials

17 trials for Hypercholesterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 unknown. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Unknown 17

Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia
Evolocumab, Ezetimibe, Placebo - Hypercholesterolemia, CKD Stage 5
Phase 4UnknownPoliclinico Casilino ASL RMB502020-11-012020-12-17
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
Evolocumab, Placebo, Ezetimibe - Hypercholesterolemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 4UnknownPoliclinico Casilino ASL RMB502020-05-042020-05-26
Effect of Atorvastatin on Carotid Intima Media Thickness
Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment - Essential Hypertension, Hypercholesterolemia
Phase 4UnknownYerevan State Medical University2002020-04-152020-03-13
Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population
Simvastatin 40mg, Ezetimibe/simvastatin 10/20 mg/day, Ezetimibe/simvastatin 10/40 mg/day - Hypercholesterolemia, Chronic Kidney Diseases
Phase 4UnknownHue University of Medicine and Pharmacy302018-06-152019-08-13
Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia
Food supplement - Hypercholesterolemia
Phase 4UnknownMeir Medical Center602013-05-012013-05-08
Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
Atorvastatin, Placebo - Type 2 Diabetes Mellitus, Hypercholesterolemia
Phase 4UnknownUniversity of Roma La Sapienza602011-03-012015-05-28
The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris
pravastatin, rosuvastatin - Coronary Disease, Hypercholesterolemia
Phase 4UnknownYokohama City University Medical Center1502011-03-012011-04-01
Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia
Rosuvastatin, Ezetimibe - Hypercholesterolemia
Phase 4UnknownBronx VA Medical Center302009-09-012009-09-10
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
Omega-3 acid 4 grams per day, Placebo control - Diabetes Mellitus, Type 2, Hypercholesterolemia
Phase 4UnknownInje University702009-07-012009-08-06
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
Atorvastatin, Lifestyle counseling - Atherosclerosis, Inflammation
Phase 4UnknownNational Defense Medical College, Japan302009-06-012013-03-12
Korean AMADEUS Study
Atorvastatin, 10mg, 20mg, 40mg - Diabetes Mellitus, Hypercholessterolemia
Phase 4UnknownThe Catholic University of Korea5002009-02-012010-11-15
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
simvastatin, EZE/simvastatin - Hypercholesterolemia, Chronic Nephropathy
Phase 4UnknownAzienda Ospedaliero Universitaria di Sassari302008-11-012009-04-28
A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis
Atorvastatin, Ezetimibe - Coronary Heart Disease, Diabetes Mellitus
Phase 4UnknownAbant Izzet Baysal University2007-01-012007-02-12
Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?
Rosuvastatin, Exercise Training - Nonfamilial Hypercholesterolemia, Physical Inactivity
Phase 4UnknownPurdue University482006-02-012007-04-20
Fluvastatin After Heart Transplantation
fluvastatin - Heart Transplantation, Hypercholesterolemia
Phase 4UnknownUniversity of Bologna562004-11-012009-04-29
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients
nucleoside analogue sparing HAART regimen - HIV-Associated Lipodystrophy Syndrome
Phase 4UnknownDanish HIV Research Group1002003-06-012006-03-14
Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease
Stepwise therapy for dyslipidemia, hypertension and diabetes, Dietary recommendations, Increase in physical activity - Peripheral Arterial Disease, Hypercholesterolemia
Phase 4UnknownHospital de Sabadell1202003-03-012005-09-05

Narrower conditions

Diabetes Mellitus (4)  ·  Coronary Disease (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Hypertension (2)  ·  Inflammation (2)  ·  Kidney Failure, Chronic (2)  ·  Renal Insufficiency, Chronic (2)  ·  Angina, Stable (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)

Broader conditions

Hyperlipidemias (17)  ·  Lipid Metabolism Disorders (17)  ·  Metabolic Diseases (17)  ·  Nutritional and Metabolic Diseases (17)  ·  Dyslipidemias (16)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (6)  ·  Endocrine System Diseases (5)  ·  Glucose Metabolism Disorders (5)  ·  Urogenital Diseases (5)  ·  Vascular Diseases (5)  ·  Cardiovascular Diseases (4)  ·  Chronic Disease (4)  ·  Disease Attributes (4)  ·  Female Urogenital Diseases (4)

Interventions

Ezetimibe (4)  ·  Atorvastatin (3)  ·  Rosuvastatin Calcium (3)  ·  Exercise (2)  ·  Simvastatin (2)  ·  evolocumab (2)  ·  Amlodipine (1)  ·  Dietary Supplements (1)  ·  Fluvastatin (1)  ·  Omacor (1)  ·  Perindopril (1)  ·  Pravastatin (1)  ·  liptruzet (1)

Sponsors

Policlinico Casilino ASL RMB (2)  ·  Abant Izzet Baysal University (1)  ·  Azienda Ospedaliero Universitaria di Sassari (1)  ·  Bronx VA Medical Center (1)  ·  Danish HIV Research Group (1)  ·  Hospital de Sabadell (1)  ·  Hue University of Medicine and Pharmacy (1)  ·  Inje University (1)  ·  Meir Medical Center (1)  ·  National Defense Medical College, Japan (1)  ·  Purdue University (1)  ·  The Catholic University of Korea (1)  ·  University of Bologna (1)  ·  University of Roma La Sapienza (1)  ·  Yerevan State Medical University (1)

Countries

Italy (5)  ·  Japan (2)  ·  South Korea (2)  ·  United States (2)  ·  Denmark (1)  ·  Israel (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  Vietnam (1)

Top investigators

Alex Laursen, M.D., DMSc (1)  ·  Andrea E Satta, MD (1)  ·  Angelo Branzi, MD (1)  ·  Ann-Brit E Hansen, M.D. (1)  ·  Court Pedersen, Professor (1)  ·  Duong Thi Ngoc Lan, Master (1)  ·  Hamayak Sisakian, MD (1)  ·  Henrik Nielsen, M.D.,DMSc (1)  ·  Jan Gerstoft, M.D., DMSc (1)  ·  Jeong H Park, M.D., Ph.D. (1)  ·  Katsunori Ikewaki (1)  ·  Kiyoshi Hibi (1)  ·  Lars Mathiesen, M.D.,DMSc (1)

Results publications

PMID 38018702, PMID 22615342, PMID 24843697, PMID 28399815, PMID 28755807